Chuang-Chuang Li

Title: Chuang-Chuang Li: Innovator in Cancer Treatment

Introduction

Chuang-Chuang Li is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for cancer treatment. His innovative approach has led to advancements in the synthesis of important compounds used in medical applications.

Latest Patents

Chuang-Chuang Li holds a patent for a method of chemical synthesis of antrocin and its use in suppressing non-small cell lung cancer. The patent describes a process for preparing antrocin and its pharmaceutically acceptable salts through a series of gold-catalyzed cyclizations to construct a (6-6-5) tricyclic core frame. This invention also outlines the use of a composition that includes an effective amount of antrocin or its salts, combined with a pharmaceutically acceptable carrier, for the treatment of non-small cell lung cancer.

Career Highlights

Throughout his career, Chuang-Chuang Li has worked with various companies, including Kaiyew Investment Corporation. His work has focused on the intersection of chemistry and medicine, leading to breakthroughs that have the potential to improve cancer treatment options.

Collaborations

Chuang-Chuang Li has collaborated with notable professionals in his field, including Zhen Yang and Yew-Min Tzeng. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chuang-Chuang Li is a prominent figure in the field of pharmaceutical innovation, particularly in cancer treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.